NG
CME icon

NatWest Group’s CME Group CME Stock Holding History

NatWest Group’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.7M Hold
60,001
– – 3.83% 8
2025
Q4 		$16.4M Hold
60,001
– – 3.81% 8
2025
Q3 		$16.2M Hold
60,001
– – 4.01% 7
2025
Q2 		$16.5M Hold
60,001
– – 4.89% 5
2025
Q1 		$15.9M Hold
60,001
– – 4.69% 3
2024
Q4 		$13.9M Hold
60,001
– – 4.12% 7
2024
Q3 		$13.2M Hold
60,001
– – 3.91% 8
2024
Q2 		$11.8M Hold
60,001
– – 4.03% 9
2024
Q1 		$12.9M Hold
60,001
– – 4.97% 5
2023
Q4 		$12.6M Hold
60,001
– – 5.28% 4
2023
Q3 		$12M Hold
60,001
– – 6.26% 3
2023
Q2 		$11.1M Hold
60,001
– – 5.78% 3
2023
Q1 		$11.5M Hold
60,001
– – 6.21% 3
2022
Q4 		$10.1M Hold
60,001
– – 5.73% 3
2022
Q3 		$10.6M Hold
60,001
– – 6.17% 3
2022
Q2 		$12.3M Hold
60,001
– – 6.97% 2
2022
Q1 		$14.3M Hold
60,001
– – 6.88% 2
2021
Q4 		$13.7M Sell
60,001
-29,528
-33% -$6.5M 7.06% 2
2021
Q3 		$17.3M Sell
89,529
-1,287
-1% -$261K 9.3% 2
2021
Q2 		$19.3M Buy
90,816
+257
+0.3% +$54.3K 9.98% 1
2021
Q1 		$18.5M Buy
90,559
+10,950
+14% +$2.16M 8.93% 1
2020
Q4 		$14.5M Buy
79,609
+457
+0.6% +$77.7K 5.33% 4
2020
Q3 		$13.2M Buy
79,152
+2,426
+3% +$409K 2.82% 16
2020
Q2 		$12.5M Buy
76,726
+23
+0% +$4.12K 3.37% 14
2020
Q1 		$13.3M Buy
76,703
+630
+0.8% +$125K 3.66% 13
2019
Q4 		$15.3M Buy
76,073
+376
+0.5% +$77.1K 3.27% 15
2019
Q3 		$16M Sell
75,697
-5
-0% -$1.04K 3.87% 12
2019
Q2 		$14.7M Buy
75,702
+960
+1% +$177K 2.68% 15
2019
Q1 		$12.3M Buy
74,742
+781
+1% +$138K 2.47% 15
2018
Q4 		$13.9M Buy
73,961
+38,342
+108% +$7.08M 3% 14
2018
Q3 		$6.06M Sell
35,619
-20
-0.1% -$3.37K 1.12% 22
2018
Q2 		$5.84M Sell
35,639
-38,631
-52% -$6.31M 1.2% 21
2018
Q1 		$12M Buy
74,270
+35,963
+94% +$5.72M 2.56% 14
2017
Q4 		$5.59M Buy
38,307
+743
+2% +$106K 1.26% 20
2017
Q3 		$5.1M Buy
37,564
+1,662
+5% +$210K 1.26% 18
2017
Q2 		$4.5M Buy
35,902
+2,072
+6% +$248K 1.04% 22
2017
Q1 		$4.02M Buy
33,830
+3,830
+13% +$461K 0.85% 30
2016
Q4 		$3.46M Hold
30,000
– – 0.91% 31
2016
Q3 		$3.14M Hold
30,000
– – 0.74% 40
2016
Q2 		$2.92M Hold
30,000
– – 0.74% 36
2016
Q1 		$2.88M Hold
30,000
– – 0.64% 38
2015
Q4 		$2.72M Buy
30,000
+19,964
+199% +$1.88M 0.55% 43
2015
Q3 		$930K Hold
10,036
– – 0.02% 201
2015
Q2 		$934K Buy
10,036
+36
+0.4% +$3.36K 0.01% 198
2015
Q1 		$947K Sell
10,000
-52
-0.5% -$4.82K 0.01% 227
2014
Q4 		$891 Sell
10,052
-130
-1% -$11K 0.01% 227
2014
Q3 		$814 Hold
10,182
– – 0.01% 282
2014
Q2 		$722K Hold
10,182
– – 0.03% 305
2014
Q1 		$754K Sell
10,182
-25,550
-72% -$1.93M 0.03% 283
2013
Q4 		$2.8M Buy
35,732
+5,175
+17% +$405K 0.07% 230
2013
Q3 		$2.26M Sell
30,557
-180,950
-86% -$13.3M 0.07% 243
2013
Q2 		$16.1M Buy
+211,507
New +$13.9M 0.23% 80

Other funds holding CME

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

NatWest Group's CME Position: Q1 2026 in Review

NatWest Group held its CME Group (CME) position steady in Q1 2026 at 60,001 shares worth $17.7M. The position accounts for 3.83% of the portfolio, ranked #8.

NatWest Group first reported a position in CME in Q2 2013 and has held it in 52 quarters since. The position peaked at $19.3M in Q2 2021. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • NatWest Group held 60,001 shares of CME Group worth $17.7M as of Q1 2026.
  • NatWest Group left its CME Group share count unchanged in Q1 2026.
  • CME Group made up 3.83% of NatWest Group's portfolio in Q1 2026, its #8 holding.
  • NatWest Group first reported a position in CME Group in Q2 2013 and has held it in 52 quarters since.
  • NatWest Group's CME Group position peaked at $19.3M in Q2 2021.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on NatWest Group's 13F filing for Q1 2026, filed 11 May 2026.